Quick Dispatch:
Your tirzepatide cardiovascular trial Tirzepatide for Heart Failure in Patients with Obesity orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide cardiovascular trial Tirzepatide for Heart Failure in Patients with Obesity ships.
Need Help?
Questions about tirzepatide cardiovascular trial Tirzepatide for Heart Failure in Patients with Obesity, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide cardiovascular trial Tirzepatide for Heart Failure in Patients with Obesity in your area.
01200-X/asset/429e6fd1-61d1-402a-91a5-b2ec86b1b878/main.assets/gr2_lrg.jpg)
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
20.75
Abstract 4361308: Tirzepatide Reduces the Risk of Major Adverse Cardiovascular Events: An Individual Participant Data Meta-analysis of Phase 3 Randomized Clinical Trials
27.29
First Patient Dose Delivered for Lilly's Tirzepatide Cardiovascular Outcomes Trial-CliniExpert
25.10
Treatment with #tirzepatide in the SUMMIT trial led to a lower risk of death from cardiovascular causes or worsening heart failure and improved health status in patients with #HFpEF and obesity. https://t.co/O9iU9a1Xgw
27.83
Tirzepatide in SURPASS‑CVOT: Favorable Cardiovascular Outcomes in Type 2 Diabetes
20.86
🔴Another GLP-1 drug success. Tirzepatide in heart failure with preserved ejection fraction (HFpEF) with longer term follow-up than 2 previous trials with semaglutide ⤵️ #AHA24 🔹In patients with heart failure with preserved
23.72
Best Time of Day to Inject Tirzepatide: Timing Guidelines
22.01
